Saqib Islam
Vorstandsvorsitzender bei SPRINGWORKS THERAPEUTICS, INC.
Vermögen: 46 Mio $ am 31.05.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Stephen P. Squinto | M | 67 |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | 31 Jahre |
Daniel Lynch | M | 65 |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | 8 Jahre |
Edgar Cale | M | 60 | 5 Jahre | |
Yung-Shin Alexander Kung | M | - |
Credit Suisse Asset Management LLC
Credit Suisse Asset Management LLC Investment ManagersFinance Founded in 1999, Credit Suisse Asset Management LLC (CSAM) is a registered investment advisor headquartered in New York City. The firm is an indirect wholly-owned subsidiary of Credit Suisse Group AG (NYSE: CS), a publicly owned foreign bank holding company based in Switzerland. | 15 Jahre |
Richard Lowenthal | M | 58 | 9 Jahre | |
Daniel Simkowitz | M | 57 | 24 Jahre | |
Jeffrey Schwartz | M | 45 |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | 7 Jahre |
Maxine Gowen | M | 66 | 3 Jahre | |
Stéphane Bancel | M | 51 |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | - |
William Chou | M | 51 | 2 Jahre | |
Michael Rongetti | M | - |
Credit Suisse Asset Management LLC
Credit Suisse Asset Management LLC Investment ManagersFinance Founded in 1999, Credit Suisse Asset Management LLC (CSAM) is a registered investment advisor headquartered in New York City. The firm is an indirect wholly-owned subsidiary of Credit Suisse Group AG (NYSE: CS), a publicly owned foreign bank holding company based in Switzerland. | 12 Jahre |
James Gorman | M | 65 | 18 Jahre | |
Shannon Klinger | M | 53 |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | - |
Deval Patrick | M | 67 |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | 3 Jahre |
Alan Fuhrman | M | 67 |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | 5 Jahre |
Freda Lewis-Hall | M | 69 |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | 7 Jahre |
Phillip Schneider | M | 68 | 5 Jahre | |
Rajeev Dadoo | M | 54 | 3 Jahre | |
Kim Diamond | F | - | 6 Jahre | |
Robert Bell | M | - | 9 Jahre | |
Sarina Tanimoto | M | 55 | 9 Jahre | |
Derrell Porter | M | 53 | 3 Jahre | |
James M. Wilson | M | - | 7 Jahre | |
Frederick Pollock | M | 44 | 18 Jahre | |
Kathleen Borthwick | F | 48 | 3 Jahre | |
Sandipkumar S. Kapadia | M | 54 | 5 Jahre | |
Herschel Weinstein | M | 68 | 4 Jahre | |
Badreddin Edris | M | 37 | 6 Jahre | |
Stephen Hoge | M | 48 |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | - |
Brian Dorsey | M | 55 | 6 Jahre | |
Michael Kelly | M | 59 | 5 Jahre | |
Peter Thompson | M | 64 | 2 Jahre | |
Pratik Shah | M | 54 | 8 Jahre | |
Alexander Fitzpatrick | M | 57 | 2 Jahre | |
Justin Chakma | M | 35 | 5 Jahre | |
Peter Kolchinsky | M | 47 | 2 Jahre | |
Carlos Alban | M | 61 | 2 Jahre | |
Eric Grossman | M | 57 | 18 Jahre | |
Stuart M. Henderson | M | - | 3 Jahre | |
Athena Countouriotis | M | 52 | 4 Jahre | |
Julie Hambleton | M | 66 | 4 Jahre | |
James Cassidy | M | 65 | 3 Jahre | |
Bhavesh Ashar | M | 58 | 3 Jahre | |
Jack Szostak | M | - |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | - |
Mandell Crawley | M | 48 | 20 Jahre | |
Eric Karas | M | 52 | 2 Jahre | |
Mark Forman | M | 60 | 3 Jahre | |
Brenton Saunders | M | 56 | 3 Jahre | |
Daniel Pichl | M | 41 | 4 Jahre | |
Daniel Relovsky | M | - | 2 Jahre | |
Frank Ducomble | M | - | 18 Jahre | |
Michael Nofi | M | 53 | 5 Jahre | |
Marcello Damiani | M | 54 |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | - |
Lorence Kim | M | 49 |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | 10 Jahre |
Kathleen Scott | F | 55 | 2 Jahre | |
Laura Shawver | M | 66 | 2 Jahre | |
Peter Hutt | M | 89 |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | 12 Jahre |
Frank Perier | M | 64 | 5 Jahre | |
Sarah Marshall | F | - | 10 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Bruce Goldsmith | M | 58 | 2 Jahre | |
David Brennan | M | 70 | 7 Jahre | |
Joseph A. Madri | M | 80 | 22 Jahre | |
Michael Altman | M | 42 | 1 Jahre | |
Jonathan Pruzan | M | 55 | 18 Jahre | |
Jim Kasinger | M | 52 |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | 3 Jahre |
Thomas R. Nides | M | 63 | 5 Jahre | |
Adam Stone | M | 44 | 1 Jahre | |
Lara Sullivan | M | 51 |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | 1 Jahre |
Robert Scott | M | 78 | 2 Jahre | |
Mark Day | M | 52 | 2 Jahre | |
Liam Ratcliffe | M | 60 | 3 Jahre | |
Israel Ruiz | M | 52 | - | |
Jens Renstrup | M | 59 | 6 Jahre | |
L. Smith | M | 57 | 7 Jahre | |
Michael V. Greco | M | 53 | 1 Jahre | |
Lisa Lejuwaan | F | - | - | |
Juan Andres | M | 59 | 6 Jahre | |
Scott Peters | M | - | 8 Jahre | |
Ruth Porat | F | 66 | 12 Jahre | |
Konstantin Poukalov | M | 40 | 1 Jahre | |
Felix Baker | M | 55 | 6 Jahre | |
John Carl Hahn | M | 66 | 11 Jahre | |
Max E. Link | M | 84 | 22 Jahre | |
Larry L. Mathis | M | 80 | 10 Jahre | |
Bradley Campbell | M | 48 | - | |
Michael Kamarck | M | 73 | 1 Jahre | |
M. Burns | F | 66 | 4 Jahre | |
Carl Gordon | M | 59 | 2 Jahre | |
Joseph Edelman | M | 67 | 1 Jahre | |
Gary W. Parr | M | 67 | 9 Jahre | |
Jordan Low | M | - |
Credit Suisse Asset Management LLC
Credit Suisse Asset Management LLC Investment ManagersFinance Founded in 1999, Credit Suisse Asset Management LLC (CSAM) is a registered investment advisor headquartered in New York City. The firm is an indirect wholly-owned subsidiary of Credit Suisse Group AG (NYSE: CS), a publicly owned foreign bank holding company based in Switzerland. | 4 Jahre |
Eileen Murray | F | 66 | 2 Jahre | |
William Keller | M | 75 | 6 Jahre | |
Moncef Slaoui | M | 64 | 3 Jahre | |
Jack Mollen | M | 73 | 7 Jahre | |
Thomas Woiwode | M | 52 | 5 Jahre | |
Christopher Coughlin | M | 71 | 7 Jahre | |
Klaus Svendsen | M | - | 3 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 98 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Saqib Islam
- Persönliches Netzwerk